News for Homology Medicines Stock (FIXX)

Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting

GlobeNewsWire • 10/27/22

Homology Medicines to Participate at Upcoming Conferences

GlobeNewsWire • 10/06/22

Homology Medicines Appoints Albert Seymour, Ph.D., Chief Executive Officer

GlobeNewsWire • 09/06/22

Homology Medicines (FIXX) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research • 08/15/22

Homology Medicines Reports Second Quarter 2022 Financial Results, Recent Highlights and Provides Business Update

GlobeNewsWire • 08/15/22

Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy

GlobeNewsWire • 08/11/22

Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low Affinity for the Liver

GlobeNewsWire • 07/05/22

Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU

GlobeNewsWire • 06/29/22

FIXX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 24, 2022 in the Class Action Filed on Behalf of Homology Medicines, Inc. Limited Shareholders

Newsfile Corp • 05/24/22

SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXX

PRNewsWire • 05/24/22

Homology Class Action: Levi & Korsinsky Reminds Homology Medicines, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 24, 2022 - FIXX

Newsfile Corp • 05/24/22

FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Homology Medicines, Inc. (FIXX) Shareholders of Class Action Last Few Hours to Actively Participate

Newsfile Corp • 05/24/22

FIXX DEADLINE TODAY: ROSEN, A TOP RANKED FIRM, Encourages Homology Medicines, Inc. Investors With Losses to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXX

Newsfile Corp • 05/24/22

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 05/24/22

FIXX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 24, 2022 in the Class Action Filed on Behalf of Homology Medicines, Inc. Shareholders

PRNewsWire • 05/24/22

FIXX LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of HOMOLOGY MEDICINES, INC. Shareholders

Newsfile Corp • 05/23/22

FIXX FINAL DEADLINE: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys Before May 24th Deadline in Securities Class Action

Newsfile Corp • 05/23/22

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 24, 2022 - (FIXX)

Newsfile Corp • 05/23/22

FIXX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - FIXX

PRNewsWire • 05/23/22

FIXX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Homology Medicines, Inc.

Newsfile Corp • 05/23/22

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 05/23/22

INVESTOR DEADLINE TOMORROW: Investors in Homology Medicines, Inc. with Substantial Losses Have Opportunity to Lead Class Action - FIXX

Newsfile Corp • 05/23/22

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Homology Investors of a Lead Plaintiff Deadline of May 24, 2022

PRNewsWire • 05/23/22

TUESDAY INVESTOR DEADLINE: Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action - FIXX

Newsfile Corp • 05/20/22

TUESDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 05/20/22